Survey of the data needs for endpoints on side effects of drug therapy in breast cancer patients.

Survey of the data needs for endpoints on side effects of drug therapy in breast cancer patients. - Survey of the data needs for endpoints on side effects of drug therapy in breast cancer patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049280

Enrollment

500

Registered

2022-10-31

Start date

2022-10-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patient is being treated or is under follow-up observation after treatment for breast cancer at a medical institution 2) Has diagnosis with breast cancer in 2002 or later 3) Has prior anti-breast cancer treatment with chemotherapy, molecular targeted drugs, or immune checkpoint inhibitors 4) Age 18 years or older 5) Has initial diagnosis of breast cancer stage 1 to 4 6) Has obtained consent to participate in this study via the Web

Exclusion criteria

Exclusion criteria: 1) Patients who expressed nonparticipation in the study prior to data fixation 2) Market research, advertising and marketing, press, healthcare professionals,or pharmaceutical company personnel 3) Persons unable to complete the questionnaire in person

Design outcomes

Primary

Measure	Time frame
(1) Side effects you have experienced (2) Side effects you have experienced for which a solution has been found (3) Side effects to avoid (4) Information you wanted to know about individual side effects before treatment	—

Countries

Japan

Contacts

Public ContactSakurako Okayasu

QLife.,Co,Ltd. Strategic Solution Plannning & Development Dept

breast-cancer@qlife.co.jp05017516834

Outcome results